Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease

Journal of Infectious Diseases

Volumn 200, Issue 12, 2009, Pages 1928-1935

  Rakhimova, Elza ^a   Wiehlmann, Lutz ^a   Brauer, Aimee L ^b   Sethi, Sanjay ^b,d   Murphy, Timothy F ^b,c,d   Tümmler, Burkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY AT BUFFALO   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENOME; BACTERIUM CARRIER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; EVOLUTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PERSISTENT INFECTION; POPULATION STRUCTURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADULT; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; YOUNG ADULT;

EID: 71949112925     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/648404     Document Type: Article

References (36)

1. 1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918-951 (Pubitemid 37267172)
2. Gómez MI, Prince A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol 2007; 7: 244-251
3. Smyth A, Elborn JS. Exacerbations in cystic fibrosis: 3-management. Thorax 2008; 63:180-184
4. 4. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15:194-222. (Pubitemid 34303763)
5. Angrill J, Agusti C, Torres A. Bronchiectasis. Curr Opin Infect Dis 2001; 14:193-197
6. 6. Angrill J, Agustí C, de Celis R, et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57:15-19 (Pubitemid 34081538)
7. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008; 14:595-599
8. Trautmann M, Lepper PM, Haller M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control 2005;33(Suppl 1): S41-9.
9. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359:2355-2365
10. 10. Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116:40-46 (Pubitemid 29340258)
11. 11. Nseir S, Di Pompeo C, Cavestri B, et al. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 2006; 34:2959-2966 (Pubitemid 44808738)
12. 12. Ferrer M, Ioanas M, Arancibia F, Marco MA, de la Bellacasa JP, Torres A. Microbial airway colonization is associated with noninvasive ventilation failure in exacerbation of chronic obstructive pulmonary disease. Crit Care Med 2005; 33:2003-2009 (Pubitemid 41306522)
13. 13. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologie etiology and lung function. Chest 1998; 113:1542-1548 (Pubitemid 28307157)
14. 14. Roseli A, Monsó E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165:891-897 (Pubitemid 40563235)
15. Martínez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008; 47:1526-1533
16. Murphy TF, Brauer AL, Eschberger K, et al.Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:853-860
17. 17. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:465-471 (Pubitemid 34879333)
18. Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005; 172:195-199
19. 19. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118:1557-1565 (Pubitemid 32001777)
20. 20. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147:1126-1131 (Pubitemid 23149867)
21. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:266-272
22. Wiehlmann L, Wagner G, Cramer N, et al. Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2007; 104:8101-8106
23. Morales G, Wiehlmann L, Gudowius P, et al. Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. J Bacteriol 2004; 186: 4228-4237
24. Mathee K, Narasimhan G, Valdes C, et al. Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad Sci U S A 2008; 105: 3100-5.
25. Maiden MC. Multilocus sequence typing of bacteria. Annu Rev Microbiol 2006; 60:561-588
26. 26. Dudoit S, Shaffer JP, Boldrick JC. Multiple hypothesis testing in microarray experiments. Stat Sci 2003; 18:71-103. (Pubitemid 41461823)
27. Römling U, Fiedler B, Bosshammer J, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 1994; 170:1616-1621
28. Jelsbak L, Johansen HK, Frost AL, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007; 75:2214-2224
29. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. Common virulence factors for bacterial pathogenicity in plants and animals. Science 1995; 268:1899-1902.
30. Liang X, Pham XQ, Olson MV, Lory S. Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa. J Bacteriol 2001; 183:843-853
31. Klockgether J, Würdemann D, Reva O, Wiehlmann L, Tümmler B. Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa. J Bacteriol 2007; 189:2443-2459
32. Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 2001; 147:2659-2669
33. Sato H, Frank DW. ExoU is a potent intracellular phospholipase. Mol Microbiol 2004; 53:1279-1290
34. de Chiai M, Ghysels B, Beatson SA, et al. Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. Microbiology 2003; 149:821-831
35. 35. Smith EE, Sims EH, Spencer DH, Kaul R, Olson MV Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol 2005; 187:2138-2147 (Pubitemid 40316244)
36. Tümmler B. Clonal variations in Pseudomonas aeruginosa. In: Ramos JL, Levesque R, eds. Pseudomonas: Molecular biology of emerging issues. Heidelberg: Springer, 2006: 35-68.